Company Filing History:
Years Active: 2015-2019
Title: Manuel Campos: Innovator in Immunological Research
Introduction
Manuel Campos is a notable inventor based in California, recognized for his contributions to immunological research. He holds 2 patents that focus on the identification of cross-reactive determinants and their applications in diagnostics and treatment.
Latest Patents
His latest patents include innovative compositions and methods for determining immunologically cross-reactive molecules. These patents specifically address proteins that comprise cross-reactive antigenic determinants. The methods involve serological screens using sequential immunological challenges to animals, which aid in identifying cross-reactive proteins. Additionally, the patents provide compositions, vaccines, and kits that utilize these molecules for diagnostics and methods aimed at preventing or treating diseases associated with infectious agents.
Career Highlights
Throughout his career, Manuel Campos has worked with prominent companies in the pharmaceutical and veterinary sectors, including Elanco Tiergesundheit AG and Novartis Tiergesundheit AG. His work has significantly impacted the field of immunology and the development of therapeutic solutions.
Collaborations
Manuel has collaborated with esteemed colleagues such as Thomas Plocher and Richard Harland, contributing to advancements in his field.
Conclusion
Manuel Campos stands out as an influential inventor in immunological research, with a focus on cross-reactive determinants that hold promise for future medical applications. His work continues to inspire innovation in the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.